(+)-catechin multiple interactions ISO RGD:1349633 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ELK1 mRNA CTD PMID:24763279 (-)-anisomycin increases phosphorylation ISO RGD:1349633 6480464 Anisomycin results in increased phosphorylation of ELK1 protein CTD PMID:12660819 (-)-anisomycin multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein], pyrazolanthrone inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] CTD PMID:12660819 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1349633 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ELK1 mRNA CTD PMID:22079256 (R)-noradrenaline multiple interactions EXP 6480464 [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein more ... CTD PMID:11880281 (S)-amphetamine multiple interactions EXP 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein], N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] CTD PMID:12377393 (S)-amphetamine increases phosphorylation EXP 6480464 Dextroamphetamine results in increased phosphorylation of ELK1 protein CTD PMID:12377393 (S)-nicotine increases phosphorylation EXP 6480464 Nicotine results in increased phosphorylation of ELK1 protein CTD PMID:29486207 (S)-nicotine increases phosphorylation ISO RGD:1349633 6480464 Nicotine results in increased phosphorylation of ELK1 protein CTD PMID:29486207 (S)-nicotine multiple interactions ISO RGD:1349633 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in increased phosphorylation of ELK1 protein] CTD PMID:29486207 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases activity ISO RGD:1349633 6480464 o, p'-DDT results in increased activity of ELK1 protein CTD PMID:18791200 1,2-dichloroethane decreases expression ISO RGD:10518 6480464 ethylene dichloride results in decreased expression of ELK1 mRNA CTD PMID:28960355 17alpha-ethynylestradiol multiple interactions ISO RGD:10518 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELK1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1349633 6480464 Estradiol results in increased phosphorylation of and results in increased activity of ELK1 protein CTD PMID:16024245 17beta-estradiol increases expression ISO RGD:1349633 6480464 Estradiol results in increased expression of ELK1 mRNA CTD PMID:23094148 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10518 6480464 Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA CTD PMID:19684285 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELK1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA CTD PMID:15897893 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10518 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELK1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1349633 6480464 Tetrachlorodibenzodioxin results in increased expression of ELK1 mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349633 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ELK1 mRNA CTD PMID:19684285 2-methyl-6-(phenylethynyl)pyridine multiple interactions EXP 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Dextroamphetamine results in increased phosphorylation of ELK1 protein] CTD PMID:12377393 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:10518 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ELK1 mRNA CTD PMID:26251327 4-hydroxynon-2-enal decreases expression ISO RGD:1349633 6480464 4-hydroxy-2-nonenal results in decreased expression of ELK1 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Fenretinide results in increased phosphorylation of ELK1 protein] CTD PMID:16407847 aflatoxin B1 decreases methylation ISO RGD:1349633 6480464 Aflatoxin B1 results in decreased methylation of ELK1 gene CTD PMID:27153756 amphetamine multiple interactions EXP 6480464 KN 62 inhibits the reaction [Amphetamine results in increased phosphorylation of ELK1 protein] CTD PMID:12060798 amphetamine increases phosphorylation EXP 6480464 Amphetamine results in increased phosphorylation of ELK1 protein CTD PMID:12060798 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1349633 6480464 pyrazolanthrone inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] more ... CTD PMID:12660819 more ... arsenic acid increases activity EXP 6480464 arsenic acid results in increased activity of ELK1 protein CTD PMID:10445758 arsenite(3-) multiple interactions ISO RGD:1349633 6480464 arsenite promotes the reaction [ELK1 protein binds to DDIT4 promoter] CTD PMID:16008523 arsenite(3-) increases activity EXP 6480464 arsenite results in increased activity of ELK1 protein CTD PMID:10445758 arsenite(3-) increases activity ISO RGD:1349633 6480464 arsenite results in increased activity of ELK1 protein CTD PMID:16008523 arsenous acid increases phosphorylation ISO RGD:1349633 6480464 Arsenic Trioxide results in increased phosphorylation of ELK1 protein CTD PMID:32683294 arsenous acid increases phosphorylation ISO RGD:10518 6480464 Arsenic Trioxide results in increased phosphorylation of ELK1 protein CTD PMID:32683294 arsenous acid multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of ELK1 protein] CTD PMID:32683294 baicalein multiple interactions ISO RGD:1349633 6480464 baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 baicalin multiple interactions ISO RGD:1349633 6480464 baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 benzene decreases expression ISO RGD:1349633 6480464 Benzene results in decreased expression of ELK1 mRNA CTD PMID:21843810 , PMID:33064461 benzo[a]pyrene increases mutagenesis ISO RGD:1349633 6480464 Benzo(a)pyrene results in increased mutagenesis of ELK1 gene CTD PMID:25435355 benzo[a]pyrene decreases methylation ISO RGD:1349633 6480464 Benzo(a)pyrene results in decreased methylation of ELK1 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1349633 6480464 Benzo(a)pyrene results in increased methylation of ELK1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1349633 6480464 Benzo(a)pyrene affects the methylation of ELK1 5' UTR, Benzo(a)pyrene affects the methylation of ELK1 exon CTD PMID:27901495 , PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ELK1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects methylation ISO RGD:10518 6480464 bisphenol A affects the methylation of ELK1 promoter CTD PMID:27334623 butyric acid increases activity ISO RGD:1349633 6480464 Butyric Acid results in increased activity of ELK1 protein CTD PMID:15103026 butyric acid multiple interactions ISO RGD:1349633 6480464 U 0126 inhibits the reaction [Butyric Acid results in increased activity of ELK1 protein] CTD PMID:15103026 cadmium dichloride increases expression ISO RGD:1349633 6480464 Cadmium Chloride results in increased expression of ELK1 mRNA CTD PMID:33129824 cadmium sulfate multiple interactions ISO RGD:1349633 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] affects the expression of ELK1 mRNA CTD PMID:18654764 cannabidiol decreases expression ISO RGD:1349633 6480464 Cannabidiol results in decreased expression of ELK1 mRNA CTD PMID:32992648 cannabidiol multiple interactions ISO RGD:1349633 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ELK1 mRNA CTD PMID:32992648 carbon nanotube decreases expression ISO RGD:10518 6480464 Nanotubes more ... CTD PMID:25554681 chromium(6+) increases phosphorylation ISO RGD:10518 6480464 chromium hexavalent ion results in increased phosphorylation of ELK1 protein CTD PMID:19654923 chrysin multiple interactions ISO RGD:1349633 6480464 chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 cisplatin multiple interactions ISO RGD:1349633 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ELK1 mRNA CTD PMID:27392435 clozapine decreases phosphorylation ISO RGD:10518 6480464 Clozapine results in decreased phosphorylation of ELK1 protein CTD PMID:12871586 cobalt dichloride multiple interactions ISO RGD:1349633 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] affects the expression of ELK1 mRNA CTD PMID:18654764 copper atom multiple interactions ISO RGD:1349633 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ELK1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1349633 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ELK1 mRNA CTD PMID:30911355 copper(II) sulfate increases activity ISO RGD:1349633 6480464 Copper Sulfate results in increased activity of ELK1 protein CTD PMID:10564177 copper(II) sulfate multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Copper Sulfate results in increased activity of ELK1 protein] CTD PMID:10564177 coumestrol multiple interactions ISO RGD:1349633 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA CTD PMID:19167446 crocidolite asbestos increases phosphorylation EXP 6480464 [Asbestos more ... CTD PMID:12495932 curcumin multiple interactions ISO RGD:1349633 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA] more ... CTD PMID:18316600 , PMID:23452621 curcumin increases phosphorylation ISO RGD:1349633 6480464 Curcumin results in increased phosphorylation of ELK1 protein CTD PMID:18316600 cycloheximide increases expression ISO RGD:1349633 6480464 Cycloheximide results in increased expression of ELK1 mRNA CTD PMID:19684285 cycloheximide multiple interactions ISO RGD:1349633 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ELK1 mRNA CTD PMID:19684285 daidzein multiple interactions EXP 6480464 daidzein results in increased phosphorylation of and results in increased activity of ELK1 protein CTD PMID:16972265 DDT increases activity ISO RGD:1349633 6480464 DDT results in increased activity of ELK1 protein CTD PMID:18791200 deoxynivalenol increases expression ISO RGD:1349633 6480464 deoxynivalenol results in increased expression of ELK1 protein CTD PMID:33890134 diarsenic trioxide multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of ELK1 protein] CTD PMID:32683294 diarsenic trioxide increases phosphorylation ISO RGD:10518 6480464 Arsenic Trioxide results in increased phosphorylation of ELK1 protein CTD PMID:32683294 diarsenic trioxide increases phosphorylation ISO RGD:1349633 6480464 Arsenic Trioxide results in increased phosphorylation of ELK1 protein CTD PMID:32683294 dibromoacetic acid increases expression ISO RGD:10518 6480464 dibromoacetic acid results in increased expression of ELK1 mRNA CTD PMID:29155130 dicrotophos increases expression ISO RGD:1349633 6480464 dicrotophos results in increased expression of ELK1 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of ELK1 mRNA CTD PMID:22546817 dioxygen multiple interactions ISO RGD:1349633 6480464 3 more ... CTD PMID:23452621 , PMID:32992648 dioxygen increases expression ISO RGD:1349633 6480464 Oxygen deficiency results in increased expression of ELK1 mRNA CTD PMID:23452621 Enterolactone multiple interactions ISO RGD:1349633 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA CTD PMID:19167446 erlotinib hydrochloride multiple interactions ISO RGD:1349633 6480464 Erlotinib Hydrochloride inhibits the reaction [EGF protein results in increased activity of ELK1 protein], Erlotinib Hydrochloride inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 , PMID:30364229 ethanol multiple interactions EXP 6480464 N-methyl-N-(6-methoxy-1-phenyl-1 more ... CTD PMID:20655511 ethanol affects splicing ISO RGD:10518 6480464 Ethanol affects the splicing of ELK1 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ELK1 mRNA CTD PMID:20655511 eticlopride(1+) increases phosphorylation ISO RGD:10518 6480464 eticlopride results in increased phosphorylation of ELK1 protein CTD PMID:12871586 galangin multiple interactions ISO RGD:1349633 6480464 galangin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 genistein multiple interactions ISO RGD:1349633 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA] CTD PMID:23452621 haloperidol increases phosphorylation ISO RGD:10518 6480464 Haloperidol results in increased phosphorylation of ELK1 protein CTD PMID:12871586 haloperidol multiple interactions EXP 6480464 Nifedipine affects the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] CTD PMID:17913375 haloperidol increases phosphorylation EXP 6480464 Haloperidol results in increased phosphorylation of ELK1 protein CTD PMID:17913375 haloperidol multiple interactions ISO RGD:10518 6480464 SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] CTD PMID:12871586 hydrogen cyanide decreases expression ISO RGD:10518 6480464 Hydrogen Cyanide results in decreased expression of ELK1 mRNA CTD PMID:33914522 hydrogen peroxide decreases expression ISO RGD:1349633 6480464 Hydrogen Peroxide results in decreased expression of ELK1 mRNA CTD PMID:12419474 indometacin decreases phosphorylation EXP 6480464 Indomethacin results in decreased phosphorylation of ELK1 protein CTD PMID:32128977 lead(II) chloride multiple interactions ISO RGD:1349633 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] affects the expression of ELK1 mRNA CTD PMID:18654764 leflunomide multiple interactions ISO RGD:1349633 6480464 Leflunomide inhibits the reaction [EGF protein results in increased activity of ELK1 protein] CTD PMID:30364229 letrozole increases expression ISO RGD:10518 6480464 letrozole results in increased expression of ELK1 protein CTD PMID:15967659 mancozeb increases phosphorylation ISO RGD:1349633 6480464 mancozeb results in increased phosphorylation of ELK1 protein CTD PMID:21375462 maneb multiple interactions ISO RGD:10518 6480464 [Maneb co-treated with Paraquat] results in decreased expression of ELK1 mRNA, Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of ELK1 mRNA] CTD PMID:23963992 melatonin multiple interactions ISO RGD:10518 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of ELK1 mRNA] CTD PMID:23963992 methoxyacetic acid multiple interactions ISO RGD:1349633 6480464 methoxyacetic acid promotes the reaction [EGF protein results in increased activity of ELK1 protein] more ... CTD PMID:15103026 methoxyacetic acid increases activity ISO RGD:1349633 6480464 methoxyacetic acid results in increased activity of ELK1 protein CTD PMID:15103026 Mitotane increases activity ISO RGD:1349633 6480464 Mitotane results in increased activity of ELK1 protein CTD PMID:18791200 morphine increases activity ISO RGD:10518 6480464 Morphine results in increased activity of ELK1 protein CTD PMID:22454534 morphine multiple interactions ISO RGD:10518 6480464 [Morphine results in increased activity of ELK1 protein] which results in increased expression of EGR4 mRNA CTD PMID:22454534 morphine affects response to substance ISO RGD:10518 6480464 ELK1 protein affects the susceptibility to Morphine CTD PMID:22454534 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1349633 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of and affects the localization of ELK1 protein more ... CTD PMID:26264181 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ELK1 mRNA CTD PMID:22546817 nicotine multiple interactions ISO RGD:1349633 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in increased phosphorylation of ELK1 protein] CTD PMID:29486207 nicotine increases phosphorylation ISO RGD:1349633 6480464 Nicotine results in increased phosphorylation of ELK1 protein CTD PMID:29486207 nicotine increases phosphorylation EXP 6480464 Nicotine results in increased phosphorylation of ELK1 protein CTD PMID:29486207 nifedipine multiple interactions EXP 6480464 Nifedipine affects the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] CTD PMID:17913375 ochratoxin A increases phosphorylation EXP 6480464 ochratoxin A results in increased phosphorylation of ELK1 protein CTD PMID:17651772 ozone multiple interactions ISO RGD:1349633 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ELK1 mRNA, [Oxygen co-treated with Ozone] results in decreased expression of ELK1 mRNA CTD PMID:32992648 p-anisidine decreases expression ISO RGD:10518 6480464 4-anisidine results in decreased expression of ELK1 mRNA CTD PMID:12929121 paclitaxel decreases expression ISO RGD:10518 6480464 Paclitaxel results in decreased expression of ELK1 mRNA CTD PMID:12929121 paraquat multiple interactions ISO RGD:10518 6480464 [Maneb co-treated with Paraquat] results in decreased expression of ELK1 mRNA, Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of ELK1 mRNA] CTD PMID:23963992 phenobarbital multiple interactions ISO RGD:1349633 6480464 Phenobarbital inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 phenylephrine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of ELK1 mRNA] more ... CTD PMID:10900171 phenylephrine increases phosphorylation EXP 6480464 Phenylephrine results in increased phosphorylation of ELK1 protein CTD PMID:10900171 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ELK1 mRNA CTD PMID:10900171 phorbol 13-acetate 12-myristate increases activity ISO RGD:1349633 6480464 Tetradecanoylphorbol Acetate results in increased activity of ELK1 protein CTD PMID:18791200 phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:1349633 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of ELK1 protein CTD PMID:21375462 potassium chromate increases expression ISO RGD:1349633 6480464 potassium chromate(VI) results in increased expression of ELK1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1349633 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ELK1 mRNA CTD PMID:22079256 propranolol multiple interactions EXP 6480464 [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein more ... CTD PMID:11880281 pterostilbene multiple interactions ISO RGD:1349633 6480464 pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form] CTD PMID:19549798 quercetin increases expression ISO RGD:1349633 6480464 Quercetin results in increased expression of ELK1 mRNA CTD PMID:27514524 quercetin decreases expression ISO RGD:1349633 6480464 Quercetin results in decreased expression of ELK1 protein modified form CTD PMID:12653748 quercetin decreases phosphorylation ISO RGD:1349633 6480464 Quercetin results in decreased phosphorylation of ELK1 protein CTD PMID:12888923 quercetin multiple interactions ISO RGD:1349633 6480464 Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein], Quercetin inhibits the reaction [TGFA protein results in increased phosphorylation of ELK1 protein] CTD PMID:12888923 resveratrol multiple interactions ISO RGD:1349633 6480464 ELK1 protein affects the reaction [resveratrol results in increased expression of EGR1 protein], resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA] CTD PMID:23452621 , PMID:25645941 resveratrol increases activity ISO RGD:1349633 6480464 resveratrol results in increased activity of ELK1 protein CTD PMID:25645941 rifampicin decreases expression ISO RGD:1349633 6480464 Rifampin results in decreased expression of ELK1 mRNA CTD PMID:24552687 SB 203580 multiple interactions ISO RGD:1349633 6480464 [SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [sodium arsenite results in increased phosphorylation of ELK1 protein] more ... CTD PMID:10903806 more ... SB 203580 affects activity EXP 6480464 SB 203580 affects the activity of ELK1 protein CTD PMID:21084678 SCH 23390 multiple interactions ISO RGD:10518 6480464 SCH 23390 inhibits the reaction [Dronabinol results in increased phosphorylation of and results in increased activity of ELK1 protein] CTD PMID:11553284 serpentine asbestos increases phosphorylation EXP 6480464 [Asbestos more ... CTD PMID:12495932 SL-327 multiple interactions ISO RGD:10518 6480464 SL 327 inhibits the reaction [Dronabinol results in increased phosphorylation of and results in increased activity of ELK1 protein], SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] CTD PMID:11553284 , PMID:12871586 sodium arsenite multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased activity of ELK1 protein] more ... CTD PMID:10564177 more ... sodium arsenite increases phosphorylation ISO RGD:1349633 6480464 sodium arsenite results in increased phosphorylation of ELK1 protein CTD PMID:12660819 , PMID:21642427 sodium arsenite increases expression ISO RGD:1349633 6480464 sodium arsenite results in increased expression of ELK1 mRNA CTD PMID:12016162 sodium arsenite increases activity ISO RGD:1349633 6480464 sodium arsenite results in increased activity of ELK1 protein CTD PMID:10564177 , PMID:15292961 sodium arsenite affects expression ISO RGD:1349633 6480464 sodium arsenite affects the expression of ELK1 protein CTD PMID:17384772 sodium arsenite increases response to substance ISO RGD:1349633 6480464 ELK1 results in increased susceptibility to sodium arsenite CTD PMID:21642427 streptozocin increases phosphorylation EXP 6480464 Streptozocin results in increased phosphorylation of ELK1 protein CTD PMID:12642375 sulindac sulfide multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein] more ... CTD PMID:17599376 Tanshinone I decreases expression ISO RGD:1349633 6480464 tanshinone results in decreased expression of ELK1 mRNA CTD PMID:30506648 Tanshinone I decreases response to substance ISO RGD:1349633 6480464 ELK1 mRNA results in decreased susceptibility to tanshinone CTD PMID:30506648 temozolomide decreases expression ISO RGD:1349633 6480464 Temozolomide results in decreased expression of ELK1 mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO RGD:1349633 6480464 testosterone enanthate affects the expression of ELK1 mRNA CTD PMID:17440010 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of ELK1 gene CTD PMID:27618143 trichostatin A multiple interactions ISO RGD:1349633 6480464 U 0126 inhibits the reaction [trichostatin A results in increased activity of ELK1 protein] CTD PMID:15103026 trichostatin A increases activity ISO RGD:1349633 6480464 trichostatin A results in increased activity of ELK1 protein CTD PMID:15103026 troglitazone increases activity ISO RGD:1349633 6480464 troglitazone results in increased activity of ELK1 protein CTD PMID:11888673 urethane increases expression ISO RGD:1349633 6480464 Urethane results in increased expression of ELK1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1349633 6480464 Valproic Acid results in decreased methylation of ELK1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1349633 6480464 U 0126 inhibits the reaction [Valproic Acid promotes the reaction [EGF protein results in increased activity of ELK1 protein]] more ... CTD PMID:15103026 valproic acid increases activity ISO RGD:1349633 6480464 Valproic Acid results in increased activity of ELK1 protein CTD PMID:15103026 vanadyl sulfate increases activity ISO RGD:1349633 6480464 vanadyl sulfate results in increased activity of ELK1 protein CTD PMID:10564177 vanadyl sulfate multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadyl sulfate results in increased activity of ELK1 protein] CTD PMID:10564177 vecuronium bromide multiple interactions ISO RGD:1349633 6480464 Vecuronium Bromide inhibits the reaction [Nicotine results in increased phosphorylation of ELK1 protein] CTD PMID:29486207 vemurafenib multiple interactions ISO RGD:1349633 6480464 [KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased phosphorylation of ELK1 protein, ELK1 protein affects the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B protein] CTD PMID:27222248 vitamin E increases phosphorylation ISO RGD:1349633 6480464 Vitamin E results in increased phosphorylation of ELK1 protein CTD PMID:11522656 zinc atom multiple interactions EXP 6480464 Zinc results in increased phosphorylation of and results in increased activity of ELK1 protein CTD PMID:16960431 zinc dichloride multiple interactions EXP 6480464 zinc chloride results in increased phosphorylation of and results in increased activity of ELK1 protein CTD PMID:16960431 zinc dichloride increases activity EXP 6480464 zinc chloride results in increased activity of ELK1 protein CTD PMID:20412391 zinc sulfate multiple interactions ISO RGD:1349633 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Zinc Sulfate results in increased activity of ELK1 protein] CTD PMID:10564177 zinc sulfate increases activity ISO RGD:1349633 6480464 Zinc Sulfate results in increased activity of ELK1 protein CTD PMID:10564177 zinc(0) multiple interactions EXP 6480464 Zinc results in increased phosphorylation of and results in increased activity of ELK1 protein CTD PMID:16960431 zoledronic acid increases expression ISO RGD:1349633 6480464 zoledronic acid results in increased expression of ELK1 mRNA CTD PMID:20977926
